News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
331,769 Results
Type
Article (24503)
Company Profile (108)
Press Release (307158)
Section
Business (116611)
Career Advice (1087)
Deals (17043)
Drug Delivery (75)
Drug Development (34782)
Employer Resources (150)
FDA (6516)
Job Trends (8092)
News (174963)
Policy (13153)
Tag
Academia (1761)
Alliances (25496)
Alzheimer's disease (743)
Approvals (6513)
Artificial intelligence (120)
Bankruptcy (101)
Best Places to Work (6609)
Biotechnology (63)
Breast cancer (82)
Cancer (777)
Career advice (930)
Cell therapy (165)
Clinical research (27551)
Collaboration (367)
Compensation (61)
COVID-19 (1243)
C-suite (100)
Data (765)
Diabetes (102)
Diagnostics (3540)
Earnings (48452)
Employer resources (129)
Events (48374)
Executive appointments (356)
FDA (6871)
Funding (289)
Gene therapy (112)
GLP-1 (339)
Government (1929)
Healthcare (8497)
Infectious disease (1299)
Inflammatory bowel disease (67)
Interviews (156)
IPO (7872)
Job creations (1771)
Job search strategy (834)
Layoffs (194)
Legal (2426)
Lung cancer (142)
Manufacturing (127)
Medical device (6055)
Medtech (6059)
Mergers & acquisitions (9344)
Metabolic disorders (248)
Neuroscience (931)
NextGen: Class of 2025 (3110)
Non-profit (2379)
Northern California (882)
Obesity (149)
Opinion (110)
People (36067)
Phase I (7782)
Phase II (11641)
Phase III (10372)
Pipeline (341)
Postmarket research (1198)
Preclinical (3806)
Press Release (63)
Radiopharmaceuticals (119)
Rare diseases (123)
Real estate (3350)
Regulatory (9506)
Research institute (1559)
Resumes & cover letters (154)
Series A (61)
Southern California (755)
Startups (2307)
United States (7880)
Vaccines (255)
Weight loss (104)
Date
Today (65)
Last 7 days (297)
Last 30 days (1153)
Last 365 days (17447)
2025 (1125)
2024 (17677)
2023 (20589)
2022 (25953)
2021 (28752)
2020 (27035)
2019 (23954)
2018 (17795)
2017 (17597)
2016 (16691)
2015 (19295)
2014 (14114)
2013 (11545)
2012 (12511)
2011 (13072)
2010 (12076)
Location
Africa (477)
Arizona (82)
Asia (21123)
Australia (3712)
California (1970)
Canada (751)
China (210)
Colorado (104)
Connecticut (71)
Delaware (65)
Europe (49151)
Florida (292)
Georgia (72)
Illinois (179)
Indiana (157)
Japan (77)
Maryland (270)
Massachusetts (1505)
Michigan (111)
Minnesota (155)
New Jersey (639)
New York (634)
North Carolina (439)
Northern California (882)
Ohio (76)
Pennsylvania (385)
South America (698)
Southern California (755)
Texas (257)
Washington State (184)
331,769 Results for "thrombolytic science international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
October 29, 2024
·
4 min read
Job Trends
BioSpace
Showcases Life Sciences Hubs in 2025 Hotbed Maps
BioSpace
has revealed its 2025 Hotbed Maps, showcasing nine regional hot spots for life sciences activity.
January 21, 2025
·
1 min read
·
Chantal Dresner
Lone Star Bio
Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference
Cassava Sciences, Inc. today announced plans to present a virtual oral presentation at the International Conference on Alzheimer’s and Parkison’s Disease (AD/PD 2024) taking place in Lisbon, Portugal from March 5-9, 2024.
March 4, 2024
·
5 min read
Biotech Beach
OKBio -- Relaunching as Life Science Oklahoma -- to participate in BIO International Convention 2024
Oklahoma’s bioscience community is announcing a relaunch of its industry association, with the new Life Science Oklahoma bringing new leadership, a new format and renewed focus and support to businesses and organizations within the Oklahoma life sciences and healthcare communities.
June 3, 2024
·
4 min read
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
Achieve Life Sciences, Inc., a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, announced publication of the ORCA-V1 trial results in the Journal of the American Medical Association Internal Medicine.
May 6, 2024
·
9 min read
Press Releases
Lung Cancer Research Foundation and the International Association for the Study of Lung Cancer Announce First Team Science Award Grant
November 19, 2024
·
5 min read
Press Releases
Sapio Sciences Expands Collaboration With AWS to Advance Science-Aware AI Vision
October 29, 2024
·
3 min read
Career Advice
Computational Biology, Data Science Hot Areas for Oncology R&D Hiring
As market values increase for computational biology and data science, biopharma companies are looking to hire R&D professionals in those areas. A biotech talent acquisition expert shares his insights on these in-demand roles.
January 2, 2025
·
5 min read
·
Angela Gabriel
BioMidwest
Basking Biosciences Presents Novel Reversible RNA-aptamer Thrombolytic at Locus Walk RNA Innovation Conference
Basking Biosciences (Basking), a clinical-stage biopharmaceutical company, today discussed the development status of BB-031, the company’s novel, RNA-based thrombolytic for use in patients experiencing acute ischemic stroke, at the Locus Walk RNA Innovation Conference, held virtually.
May 9, 2023
·
4 min read
BioForest
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting
Achieve Life Sciences, Inc. today announced data from the Phase 2 ORCA-V1 vaping cessation trial will be presented today, Friday, May 17, 2024, at the Society of General Internal Medicine (SGIM) Annual Meeting being held in Boston, MA.
May 17, 2024
·
6 min read
1 of 33,177
Next
